
- Profil
- Réseaux sociaux
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The Bristows team are a team to be reckoned with in the fields of life sciences and healthcare. They combine excellent technical knowledge with legal nous to achieve the commercial objectives of their clients, guiding them efficiently and effectively to a valuable result. ’
‘Charlie French is excellent to work with, intelligent and responsive, manages the team effectively with ease.'
- 'Chloe Dickson is a very bright senior associate who will go far: intelligent and commercial.'
- 'Chris Stubbs is a lawyer with a great future ahead of him; brilliant technical knowledge.’
‘Bristows has always been a leader in this sector. They really know their stuff and act in many of the leading cases. Individuals are hard-working, with strong technical understanding and careful attention to detail. Brian Cordery and Charlie French are key partners.’
‘Bristows has superb breadth and in-depth technological know-how. They are wonderful life sciences litigators and have been for decades.’
‘Liz Cohen and Brian Cordery stand out. They are extremely client-focused, understand the industry and client needs and provide nothing short of first-class service every time. ’
‘My experience is of Bristows' patent litigators, who are excellent. As a team, they are particularly good at a deep understanding of the relevant technology, and applying that knowledge to tactical advantage in litigation.'
Clients clés
- Syncona
- Telix Pharmaceuticals
- Bestway Panacea Holdings Limited
- Novartis Pharmaceuticals
- Sandoz
- Teva Pharmaceutical Industries
- Mara Renewables
- Genentech
- Touchlight
- AstraZeneca
Points forts
- Advised AstraZeneca on a high profile patent deal with Chinese biotech Usynova to add to AstraZeneca’s oncology pipeline by licensing Usynova’s novel pancreatic cancer therapy in a transaction worth $420 million.
- Acting for Genentech and Novartis in ongoing UK High Court revocation and infringement proceedings against Celltrion in respect of Genentech’s and Novartis’s antibody medicine Xolair (ex-US sales $1.463 billion).
- Advising Syncona on the establishment and financing of ophthalmic gene therapy company Beacon Therapeutics, which launched in June 2023 following a £96 million Series A financing.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Les grands avocats de demain
Jeunes associés disposant d’une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.
Meilleurs collaborateurs
Jeunes avocats collaborateurs ou counsels qui se distinguent régulièrement par leur présence dans des dossiers importants du marché, et qui sont identifiés par le marché comme de jeunes talents à suivre.
Responsable de la pratique
Liz Cohen; Richard Dickinson
Autres avocats clés
Brian Cordery; Robert Burrows; Greg Bacon; Rachel Mumby; Matthew Warren; Marek Petecki; Claire Smith; Alex Denoon; David Horner; Xisca Borrás; Ellen Lambrix; Charlie French; Nick Cross; Claire Phipps-Jones; Adrian Chew; Chloe Dickson; Chris Stubbs